77 filings
Page 2 of 4
S-3
qjq5 t8loy6q1qgmes4
3 Nov 23
Shelf registration
5:23pm
8-K
om45wbcuowq5kogijqpj
3 Nov 23
Prime Medicine Reports Third Quarter 2023 Financial Results and Provides Business Updates
4:06pm
8-K
vezqftuq4ht2 dps5
7 Aug 23
Prime Medicine Reports Second Quarter 2023 Financial Results and Provides Business Updates
4:04pm
8-K
aocg1bq3dni0f
16 Jun 23
Submission of Matters to a Vote of Security Holders
4:02pm
8-K
1as nojhq6duvif9xlau
17 May 23
Prime Medicine to Present New Preclinical Data Highlighting Broad Potential of Prime Editing Technology at ASGCT 26th Annual Meeting
7:09am
DEFA14A
q8p88df
11 May 23
Additional proxy soliciting materials
8:09am
8-K
gi6bq5o4mv bqs3vo
11 May 23
Departure of Directors or Certain Officers
8:08am
8-K
p1q2hfj8zpltl1gf3
11 May 23
Prime Medicine Reports First Quarter 2023 Financial Results and Provides Business Updates
8:05am
ARS
a00331
28 Apr 23
Annual report to shareholders
8:51am
DEFA14A
1973m
28 Apr 23
Additional proxy soliciting materials
8:38am
DEF 14A
lrcl24y8gd0ip
28 Apr 23
Definitive proxy
8:34am
8-K/A
der950d3yfqkc3play0
10 Mar 23
Prime Medicine Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
8:00am
S-8
3zm2l6j0q5tsg dkn
9 Mar 23
Registration of securities for employees
4:17pm
10-K
7niejtw ylhb
9 Mar 23
Annual report
3:02pm
8-K
2ucpcducd3c64
9 Mar 23
Prime Medicine Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
8:26am
8-K
prala035a 9yudsb3
9 Jan 23
Regulation FD Disclosure
4:03pm
10-Q
5aq7y0eu
14 Nov 22
Quarterly report
4:46pm